Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Standard Medical Management or Enhanced Medical Management for Opioid Analgesic Dependence

NCT00316277 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT00316277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00316277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Standard Medical Management or Enhanced Medical Management for Opioid Analgesic Dependence
Lead sponsor
Mclean Hospital
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2006
Completion date
January 31, 2013
Enrollment
653 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

opiate dependence, opioid-related disorders, substance-related disorders